Jenny Rinke

710 total citations
22 papers, 385 citations indexed

About

Jenny Rinke is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Jenny Rinke has authored 22 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 14 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Jenny Rinke's work include Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Jenny Rinke is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Jenny Rinke collaborates with scholars based in Germany, United Kingdom and Australia. Jenny Rinke's co-authors include Andreas Hochhaus, Thomas Ernst, Vivien Schäfer, Claudia Haferlach, Nils Winkelmann, Jana Ernst, Nicholas C.P. Cross, Bernd Gruhn, Susanne Schnittger and Torsten Haferlach and has published in prestigious journals such as Blood, Clinical Chemistry and British Journal of Haematology.

In The Last Decade

Jenny Rinke

21 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jenny Rinke Germany	11	287	201	155	56	51	22	385
W. M. C. Geertsma-Kleinekoort Netherlands	6	291 1.0×	127 0.6×	180 1.2×	33 0.6×	30 0.6×	7	426
Paula de Melo Campos Brazil	11	168 0.6×	83 0.4×	147 0.9×	34 0.6×	30 0.6×	43	353
Abdulsamad Wafa Syria	10	173 0.6×	126 0.6×	75 0.5×	66 1.2×	71 1.4×	51	300
Gautam Borthakur United States	12	415 1.4×	215 1.1×	211 1.4×	98 1.8×	92 1.8×	83	494
Jiřı́ Schwarz Czechia	11	245 0.9×	249 1.2×	220 1.4×	41 0.7×	64 1.3×	36	403
Jana Linhartová Czechia	7	191 0.7×	120 0.6×	46 0.3×	79 1.4×	37 0.7×	13	242
Berna Beverloo Netherlands	6	159 0.6×	60 0.3×	143 0.9×	50 0.9×	25 0.5×	18	260
Hyun‐Gyung Goh South Korea	11	342 1.2×	290 1.4×	82 0.5×	54 1.0×	171 3.4×	19	463
Harmony Leroy France	5	340 1.2×	134 0.7×	155 1.0×	91 1.6×	8 0.2×	9	382
Kathleen C. Rayeroux Australia	6	109 0.4×	91 0.5×	109 0.7×	29 0.5×	37 0.7×	10	224

Countries citing papers authored by Jenny Rinke

Since Specialization

Citations

This map shows the geographic impact of Jenny Rinke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Rinke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Rinke more than expected).

Fields of papers citing papers by Jenny Rinke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Rinke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Rinke. The network helps show where Jenny Rinke may publish in the future.

Co-authorship network of co-authors of Jenny Rinke

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Rinke. A scholar is included among the top collaborators of Jenny Rinke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Rinke. Jenny Rinke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rinke, Jenny, Andrew J. Walter, Manja Meggendorfer, et al.. (2025). Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis. Annals of Hematology. 104(5). 2755–2763.

Rinke, Jenny, et al.. (2025). Therapy-induced senescence of glioblastoma cells is determined by the p21CIP1-CDK1/2 axis and does not require activation of DREAM. Cell Death and Disease. 16(1). 357–357. 3 indexed citations

Rinke, Jenny, Thomas Ernst, Nina Hahn, et al.. (2024). µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics. Molecular Systems Biology. 20(8). 972–995. 10 indexed citations

Wickel, Jonathan, Ulf Schnetzke, Jenny Rinke, et al.. (2024). Anti-CD19 CAR-T cells are effective in severe idiopathic Lambert-Eaton myasthenic syndrome. Cell Reports Medicine. 5(11). 101794–101794. 5 indexed citations

Ernst, Thomas, Jenny Rinke, Philipp le Coutre, et al.. (2024). The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients. Blood. 144(Supplement 1). 1774–1774. 2 indexed citations

Rinke, Jenny, Ingrid Sander, Manja Meggendorfer, et al.. (2024). Molecular and Clinical Risk Factors Associated with Thrombosis and Bleeding in Myelofibrosis Patients. Hämostaseologie. 1 indexed citations

Rinke, Jenny, et al.. (2023). Molecular‐defined clonal evolution in patients with classical myeloproliferative neoplasms. British Journal of Haematology. 202(2). 308–317. 4 indexed citations

Ernst, Thomas, Philipp le Coutre, Martina Crysandt, et al.. (2023). S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.. HemaSphere. 7(S3). e34543a6–e34543a6. 9 indexed citations

Rinke, Jenny, Vivien Schäfer, Thomas Schenk, et al.. (2022). ASXL1 mutations predict inferior molecular response to nilotinib treatment in chronic myeloid leukemia. Leukemia. 36(9). 2242–2249. 25 indexed citations

10.

Rinke, Jenny, Andreas Hochhaus, & Thomas Ernst. (2020). CML - Not only BCR-ABL1 matters. Best Practice & Research Clinical Haematology. 33(3). 101194–101194. 11 indexed citations

11.

Rinke, Jenny, Florian Perner, Jana Ernst, et al.. (2020). Prevalence and dynamics of clonal hematopoiesis caused by leukemia-associated mutations in elderly individuals without hematologic disorders. Leukemia. 34(8). 2198–2205. 38 indexed citations

12.

Rinke, Jenny, et al.. (2019). 5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes. Journal of Cancer Research and Clinical Oncology. 145(11). 2835–2843. 12 indexed citations

13.

Ernst, Thomas, Jenny Rinke, Jana Ernst, et al.. (2018). Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia. Leukemia. 32(9). 2046–2049. 34 indexed citations

14.

Winkelmann, Nils, Vivien Schäfer, Jenny Rinke, et al.. (2017). Only SETBP1 hotspot mutations are associated with refractory disease in myeloid malignancies. Journal of Cancer Research and Clinical Oncology. 143(12). 2511–2519. 6 indexed citations

15.

Rinke, Jenny, Jörg P. Müller, Markus Blaess, et al.. (2017). Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms. Leukemia. 31(9). 1936–1943. 23 indexed citations

16.

Schäfer, Vivien, Jana Ernst, Jenny Rinke, et al.. (2016). EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia. Journal of Cancer Research and Clinical Oncology. 142(7). 1641–1650. 28 indexed citations

17.

Schmidt, Mathias, Jenny Rinke, Vivien Schäfer, et al.. (2014). Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status. Leukemia. 28(12). 2292–2299. 88 indexed citations

18.

Ernst, Thomas, Mathias Schmidt, Jenny Rinke, et al.. (2014). Molecularly Defined Clonal Evolution in Patients with Chronic Myeloid Leukemia Independent of the BCR-ABL Status. Blood. 124(21). 4513–4513. 2 indexed citations

19.

Baumann, Klaus, et al.. (2013). Effects of alvocidib and carboplatin on ovarian cancer cells in vitro.. PubMed. 35(3). 168–73. 6 indexed citations

20.

Schwaab, Juliana, Thomas Ernst, Philipp Erben, et al.. (2012). Activating CBL mutations are associated with a distinct MDS/MPN phenotype. Annals of Hematology. 91(11). 1713–1720. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact